Life science companies are increasingly investing in artificial intelligence (AI), recognizing its potential to drive significant growth across functional areas. AI could help accelerate drug discovery, optimize clinical trials, and enhance disease diagnosis to bridge innovation with real-world healthcare.

However, businesses are encouraged to understand the AI risks that could lead to complex disputes.  

Please join DLA Piper attorneys as they discuss key cross-disciplinary challenges for life sciences companies and provide an update on current disputes before the courts. 

This webinar aims to provide a greater understanding of key issues and challenges within the industry, helping you protect your business from legal risks. 

Read our latest insights: new DLA Piper AI Alert, "DOJ and SEC send warning on “AI washing” with charges against technology startup founder"
 

Upcoming sessions in our AI disputes webinar series

Futureproofing technology against AI disputes
Thursday, May 29, 2025
12:00 pm – 1:00 pm ET

Causing collusion? Understanding antitrust considerations when using AI
Tuesday, June 24, 2025 
1:00 pm – 2:00 pm ET

View series website to learn more and register.